tiprankstipranks
Trending News
More News >
KalVista Pharmaceuticals (KALV)
NASDAQ:KALV

KalVista Pharmaceuticals (KALV) Similar Stocks

Compare
580 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
KalVista Pharmaceuticals
$15.17
$766.79M
-3.79
77.84%
9 Buy
0 Hold
0 Sell
Strong Buy
Savara
$6.45
$1.31B
-12.05
104.76%
6 Buy
0 Hold
0 Sell
Strong Buy
Arvinas Holding Company
$12.16
$780.97M
-15.14
-36.00%
5 Buy
4 Hold
1 Sell
Moderate Buy
Gossamer Bio
$3.23
$747.60M
-4.70
280.00%
3 Buy
1 Hold
0 Sell
Strong Buy
Compass Therapeutics
$5.17
$919.55M
-11.30
254.11%
7 Buy
0 Hold
0 Sell
Strong Buy
Bicara Therapeutics Inc.
$16.80
$920.34M
-7.53
-8.05%
7 Buy
2 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
KALV
KalVista Pharmaceuticals
15.17
6.78
80.81%
SVRA
Savara
6.45
3.37
109.42%
ARVN
Arvinas Holding Company
12.16
-6.84
-36.00%
GOSS
Gossamer Bio
3.23
2.35
267.05%
CMPX
Compass Therapeutics
5.17
3.69
249.32%
BCAX
Bicara Therapeutics Inc.
16.80
-0.20
-1.18%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts